How vascular smooth muscle cell phenotype switching contributes to vascular disease.
Cao G, Xuan X, Hu J, Zhang R, Jin H, Dong H. · 2022
Read How vascular smooth muscle cell phenotype switching contributes to vascular disease. by Cao G, Xuan X, Hu J, Zhang R, Jin H, Dong H. (2022) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc9677683.txt.
Introduction
Cao and co-authors explain how vascular smooth muscle cell switching of type feeds vascular disease. These cells are the most common cell in vessel walls. They hold a high power to change their form and job. Injury flips them into a fast moving growth state for repair.
Single-cell tools have shown far more switch states since. Switched cells drop their squeeze proteins, such as alpha-SMA. They can take on traits of bone, fibroblast, or macrophage cells. Mesenchymal-like states appear in the mix as well. A wide control web drives these flips in form. Blood borne factors, growth signals, and non-coding RNAs all play in. The review maps each state and its work in lesions. It then ties switching to vessel ageing and hardening. Aneurysm growth is the third disease in the frame.
Catalog record
| CREATOR | Cao G, Xuan X, Hu J, Zhang R, Jin H, Dong H. |
|---|---|
| YEAR | 2022 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 110 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
How vascular smooth muscle cell phenotype switching contributes to vascular disease By Genmao Cao, Xuezhen Xuan, Jie Hu, Ruijing Zhang, Haijiang Jin, Honglin Dong Published in: Cell Communication and Signaling : CCS DOI: 10.1186/s12964-022-00993-2 ABSTRACT Vascular smooth muscle cells (VSMCs) are the most abundant cell in vessels. Earlier experiments have found that VSMCs possess high plasticity. Vascular injury stimulates VSMCs to switch into a dedifferentiated type, also known as synthetic VSMCs, with a high migration and proliferation capacity for repairing vascular injury. In recent years, largely owing to rapid technological advances in single-cell sequencing and cell-lineage tracing techniques, multiple VSMCs phenotypes have been uncovered in vascular aging, atherosclerosis (AS), aortic aneurysm (AA), etc. These VSMCs all down-regulate contractile proteins such as α-SMA and calponin1, and obtain specific markers and similar cellular functions of osteoblast, fibroblast, macrophage, and mesenchymal cells. This highly plastic phenotype transformation is regulated by a complex network consisting of circulating plasma substances, transcription factors, growth factors, inflammatory factors, non-coding RNAs, integrin family, and Notch pathway. This review focuses on phenotypic characteristics, molecular profile and the functional role of VSMCs phenotype landscape; the molecular mechanism regulating VSMCs phenotype switching; and the contribution of VSMCs phenotype switching to vascular aging, AS, and AA. Video Abstract Supplementary Information The online version contains supplementary material available at 10.1186/s12964-022-00993-2. INTRODUCTION Over the last three decades, cardiovascular disease (CVD) has been reported as the primary cause of morbidity and mortality worldwide [1, 2]. The pathophysiological basis of vascular diseases involves a wide range of mechanisms including vascular aging, calcification, atherosclerosis, extracellular matrix (ECM) remodeling, and immune cells infiltration. VSMCs are the most abundant cell type in vessels that not only exert vascular physiological function but also contribute to vascular diseases in varied ways. Recent studies indicated that VSMCs display a high degree of plasticity and possess multiple differentiation potentials in disease states, finally achieving unexpected phenotypes with changes in morphology and function. It is interesting to note that VSMCs phenotype transformation could be multi-directional in a single local lesion. According to literature reports, the process involves metabolism dysfunction, stress response, inter-cellular communication, and multi-level signaling pathways, which together constitute a sophisticated regulatory network. Due to the significant correlation between VSMCs phenotype and the occurrence and progression of vascular diseases, manifold studies have pointed out that VSMCs phenotype switching underlies the progression of vascular diseases, and found that inhibition of VSMCs switching from contractile to other phenotypes helps alleviate the severity of vascular diseases. Studies on VSMCs phenotype switching not only elucidate a new mechanism of vascular diseases but also provide a new therapeutic target. This review summarizes the characteristics and functions of existing VSMCs phenotypes, elaborates factors driving VSMCs phenotype switching, and elucidates the contribution of various VSMCs phenotypes to vascular diseases. We also prospect the potential of VSMCs phenotype switching as a treatment for vascular diseases. NORMAL PHYSIOLOGICAL FUNCTION OF VSMCS Anatomically, a healthy large artery is composed of a three-layer loop structure: (1) tunica intima consisting of a single layer of endothelial cells; (2) tunica media consisting of multiple VSMCs layers, and elastic fiber layers between VSMCs layers; (3) tunica adventitia containing adipocytes, fibrous connective tissue, and ECM [3]. The elasticity of artery mainly credits to active contraction of VSMCs and passive contraction of elastic lamellae that composed of collagen and elastin fibers. The contractile properties allow VSMCs to regulate vessel diameter, blood pressure, and blood flow distribution. Regarding VSMCs located in aorta, they are exposed to high pressure, shear stress, and pulsatile blood flow [4]. This additionally requires a considerable stiffness level of VSMCs. In large arteries, the VSMCs contract to maintain the normal shape of the artery during systolic ejection period. On the other hand, VSMCs in small resistance arteries are responsible for regulating blood flow distribution, reducing the diameter of the small resistance artery [5]. VSMCs contractility was regulated by active substances secreted by endothelial cells, autonomic nervous system, adrenal hormone, vasoactive peptides, and ROS. The contraction of VSMCs is triggered by ionized calcium influx. Calcium-calmodulin-mediated activation of myosin light chain phosphorylation and actin-myosin cross-bridge cycling act in concert to facilitate myofilament contractility [6]. Additionally, actin cytoskeleton modulates VSMCs contractility by communicating with ECM. Actin filaments are bound to talin and vinculin, indirectly linked to integrin β subunit [7]. Thus, contractile force in actin filaments could be conveyed to integrin receptors and then ECM through inside-out signaling. Similarly, extracellular segments of integrins bind to ligands in the ECM and transmit extracellular signals or force to actin cytoskeleton through out-inside signaling. Detailed mechanisms have been described in an excellent review [4]. THE LANDSCAPE OF VSMCS PHENOTYPES The high plasticity of VSMCs In healthy adults, the vast majority of VSMCs are located in tunica media and represent quiescent contractile phenotype. Whereas, contractile VSMCs spontaneously modify their phenotype instantaneously to a highly synthetic phenotype when the vessel is physically or chemically damaged. VSMCs phenotype switching serves as a vital step in the repair process of vascular damage. As synthetic VSMCs undergo down-regulation of contractile gene expression, cytoskeleton remodeling, and cell reprogramming, VSMCs dramatically increase their proliferation capacity and secret matrix metalloproteinases to promote extracellular matrix remodeling. The acquired proliferation and migration capacity of synthetic VSMCs benefits neointima formation following vascular injury. After injury is released, locally dysfunctional signaling pathways within the vessels restores homeostasis and the VSMCs regains their contractile phenotype/characteristics. The potential plasticity shown by VSMCs is comprehensive and inherent, since VSMCs necessitate high abilities of proliferation, migration, and ECM secretion (such as collagen and elastin) in response to vascular morphogenesis and frequent vascular injury. However, the high plasticity of VSMCs may make it susceptible to harmful environmental stimuli, thus transforming into pathogenic phenotypes. VSMCs phenotype switching is usually triggered and regulated by growth factor/inhibitors, transcription factors, mechanical force, cell–cell, and cell–matrix interactions, as well as a variety of inflammatory mediators [8]. Synthetic VSMCs The synthetic VSMCs are considered as the de-differentiated state of contractile VSMCs, accompanied by morphologic changes from spindle shape to irregular shape. With the decrease of contractile protein expression, the proliferation and migration ability of synthetic VSMCs was enhanced, which played a role in repairing vascular injury. And true to its name, synthetic VSMCs secrete large amounts of collagen, elastin, and matrix metalloproteinase (MMP) causing vascular ECM remodeling. Therefore, synthetic VSMCs almost exist in all types of vascular diseases such as atherosclerosis, aneurysm, neointima. Synthetic VSMCs are prone to further differentiate into alternative phenotypes such as macrophage-like and osteogenic VSMCs. Although some scholars believe that there is no convincing marker for the synthetic VSMC, numerous studies have confirmed that osteopontin (OPN), MMP-9, epiregulin (EREG), and vimentin (VIM) are highly expressed in the synthetic VSMC [9, 10]. A wide range of regulatory factors and signaling pathways are involved in the transition from contractile to synthetic VSMC, including metabolic factors, growth factors, non-coding RNA, immune-inflammatory molecules and so on. They will be discussed in detail in the next section. Osteogenic VSMCs Vascular calcification (VC) is a common sign in the aged population and chronic kidney disease (CKD) population, which could consequent in increased artery hardness, impaired elasticity, and deficient compliance in advanced stage. VC can be regarded as a process of osteogenesis since the activation of osteogenic genes